Mesenchymal stem cell-derived extracellular vesicles: Toward cell-free therapeutic applications

Molecular Therapy

Volumn 23, Issue 5, 2015, Pages 812-823

  Rani, Sweta ^a   Ryan, Aideen E ^a   Griffin, Matthew D ^a   Ritter, Thomas ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; BIOGENESIS; BIOLOGICAL THERAPY; BLADDER CARCINOMA; CANCER INHIBITION; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL FREE THERAPY; CLINICAL PRACTICE; DRUG DELIVERY SYSTEM; EXOSOME; HEART PROTECTION; HUMAN; INTERNALIZATION; LIVER CELL CARCINOMA; LIVER DISEASE; LUNG DISEASE; MEMBRANE MICROPARTICLE; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; NONHUMAN; PARACRINE SIGNALING; REGULATORY MECHANISM; RENAL PROTECTION; REVIEW; SKIN INJURY; WOUND HEALING; ANIMAL; METABOLISM; TRANSLATIONAL RESEARCH;

ANIMALIA;

ANIMALS; CELL-DERIVED MICROPARTICLES; EXOSOMES; EXTRACELLULAR VESICLES; HUMANS; MESENCHYMAL STROMAL CELLS; PARACRINE COMMUNICATION; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84929050359     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2015.44     Document Type: Review

References (154)

1. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, et al. (1998). Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279: 1528-1530
2. Barry FP and Murphy JM. (2004). Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36: 568-584
3. Erices A, Conget P and Minguell JJ. (2000). Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109: 235-242
4. Gang EJ, Jeong JA, Hong SH, Hwang SH, Kim SW, Yang IH, et al. (2004). Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells 22: 617-624
5. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147
6. Crapnell K, Blaesius R, Hastings A, Lennon DP, Caplan AI and Bruder SP. (2013). Growth differentiation capacity and function of mesenchymal stem cells expanded in serum-free medium developed via combinatorial screening. Exp Cell Res 319: 1409-1418
7. Griffin MD, Ryan AE, Alagesan S, Lohan P, Treacy O and Ritter T. (2013). Antidonor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?. Immunol Cell Biol 91: 40-51
8. González MA, Gonzalez-Rey E, Rico L, Büscher D and Delgado M. (2009). Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136: 978-989
9. Xin H, Li, Y and Chopp M. (2014). Exosomes/miRNAs as mediating cell-based therapy of stroke. Front Cell Neurosci 8: 377
10. Xiang MX, He, AN, Wang JA and Gui C. (2009). Protective paracrine effect of mesenchymal stem cells on cardiomyocytes. J Zhejiang Univ Sci B 10: 619-624
11. Park JH, Hwang I, Hwang SH, Han H and Ha, H. (2012). Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action. Diabetes Res Clin Pract 98: 465-473
12. Karp JM and Leng Teo GS. (2009). Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 4: 206-216
13. Wagner J, Kean T, Young R, Dennis JE and Caplan AI. (2009). Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol 20: 531-536
14. Williams AR and Hare JM. (2011). Mesenchymal stem cells: biology pathophysiology translational findings and therapeutic implications for cardiac disease. Circ Res 109: 923-940
15. Toma C, Pittenger MF, Cahill KS, Byrne BJ and Kessler PD. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93-98
16. Ringdén O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lönnies H, et al. (2006). Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81: 1390-1397
17. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, et al. (2009). Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5: 54-63
18. Parekkadan B and Milwid JM. (2010). Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12: 87-117
19. Tögel F, Hu, Z, Weiss K, Isaac J, Lange C and Westenfelder C. (2005). Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289: F31-F42
20. Tögel F, Weiss K, Yang Y, Hu, Z, Zhang P and Westenfelder C. (2007). Vasculotropic paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 292: F1626-F1635
21. Li, Y, Liu Z, Xin H and Chopp M. (2014). The role of astrocytes in mediating exogenous cell-based restorative therapy for stroke. Glia 62: 1-16
22. Xin H, Li, Y, Liu Z, Wang X, Shang X, Cui Y, et al. (2013). MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells 31: 2737-2746
23. Pan BT and Johnstone RM. (1983). Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33: 967-978
24. Simpson RJ, Jensen SS and Lim JW. (2008). Proteomic profiling of exosomes: current perspectives. Proteomics 8: 4083-4099
25. Corcoran C, Rani S, O'Brien K, O'Neill A, Prencipe M, Sheikh R, et al. (2012). Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes. PLoS One 7: e50999
26. O'Brien K, Rani S, Corcoran C, Wallace R, Hughes L, Friel AM, et al. (2013). Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells. Eur J Cancer 49: 1845-1859
27. Blanchard N, Lankar D, Faure F, Regnault A, Dumont C, Raposo G, et al. (2002). TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol 168: 3235-3241
28. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, et al. (1996). B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183: 1161-1172
29. Admyre C, Johansson SM, Paulie S and Gabrielsson S. (2006). Direct exosome stimulation of peripheral human T cells detected by ELISPOT. Eur J Immunol 36: 1772-1781
30. Li, X, Li, JJ, Yang JY, Wang DS, Zhao W, Song WJ, et al. (2012). Tolerance induction by exosomes from immature dendritic cells and rapamycin in a mouse cardiac allograft model. PLoS One 7: e44045
31. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ and Sixma JJ. (1999). Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94: 3791-3799
32. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, et al. (2010). Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4: 214-222
33. Raposo G, Tenza D, Mecheri S, Peronet R, Bonnerot C and Desaymard C. (1997). Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell 8: 2631-2645
34. van Niel G, Raposo G, Candalh C, Boussac M, Hershberg R, Cerf-Bensussan N, et al. (2001). Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 121: 337-349
35. van Balkom BW, De Jong OG, Smits M, Brummelman J, Den Ouden K, De Bree PM, et al. (2013). Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells. Blood 121: 3997-4006, S1
36. Fauré J, Lachenal G, Court M, Hirrlinger J, Chatellard-Causse C, Blot B, et al. (2006). Exosomes are released by cultured cortical neurones. Mol Cell Neurosci 31: 642-648
37. Février B and Raposo G. (2004). Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 16: 415-421
38. Gould SJ and Raposo G. (2013). As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles 2: doi:10.3402/jev.v2i0.20389
39. Colombo M, Moita C, van Niel G, Kowal J, Vigneron J, Benaroch P, et al. (2013). Analysis of ESCRT functions in exosome biogenesis composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci 126(Pt 24): 5553-5565
40. Mittelbrunn M and Sánchez-Madrid F. (2012). Intercellular communication: diverse structures for exchange of genetic information. Nat Rev Mol Cell Biol 13: 328-335
41. Tan SS, Yin Y, Lee T, Lai RC, Yeo RW, Zhang B, et al. (2013). Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane. J Extracell Vesicles 2: doi:10.3402/jev.v2i0.22614
42. Harding C, Heuser J and Stahl P. (1984). Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: demonstration of a pathway for receptor shedding. Eur J Cell Biol 35: 256-263
43. Feng D, Zhao WL, Ye, YY, Bai XC, Liu RQ, Chang LF, et al. (2010). Cellular internalization of exosomes occurs through phagocytosis. Traffic 11: 675-687
44. Morelli AE, Larregina AT, Shufesky WJ, Sullivan ML, Stolz DB, Papworth GD, et al. (2004). Endocytosis intracellular sorting and processing of exosomes by dendritic cells. Blood 104: 3257-3266
45. Svensson KJ, Christianson HC, Wittrup A, Bourseau-Guilmain E, Lindqvist E, Svensson LM, et al. (2013). Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1. J Biol Chem 288: 17713-17724
46. Akers JC, Gonda D, Kim R, Carter BS and Chen CC. (2013). Biogenesis of extracellular vesicles (EV): exosomes microvesicles retrovirus-like vesicles and apoptotic bodies. J Neurooncol 113: 1-11
47. Bergo MO, Gavino BJ, Steenbergen R, Sturbois B, Parlow AF, Sanan DA, et al. (2002). Defining the importance of phosphatidylserine synthase 2 in mice. J Biol Chem 277: 47701-47708
48. Zwaal RF and Schroit AJ. (1997). Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89: 1121-1132
49. D'Souza-Schorey C and Chavrier P. (2006). ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 7: 347-358
50. Muralidharan-Chari V, Clancy J, Plou C, Romao M, Chavrier P, Raposo G, et al. (2009). ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol 19: 1875-1885
51. Nguyen DH, Catling AD, Webb DJ, Sankovic M, Walker LA, Somlyo AV, et al. (1999). Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrinselective manner. J Cell Biol 146: 149-164
52. Muralidharan-Chari V, Clancy JW, Sedgwick A and D'Souza-Schorey C. (2010). Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 123(Pt 10): 1603-1611
53. Kilpinen L, Impola U, Sankkila L, Ritamo I, Aatonen M, Kilpinen S, et al. (2013). Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury a feature that is lost after inflammatory conditioning. J Extracell Vesicles 2: doi: 10.3402/jev.v2i0.21927
54. Salomon C, Ryan J, Sobrevia L, Kobayashi M, Ashman K, Mitchell M, et al. (2013). Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS One 8: e68451
55. Lespagnol A, Duflaut D, Beekman C, Blanc L, Fiucci G, Marine JC, et al. (2008). Exosome secretion including the DNA damage-induced p53-dependent secretory pathway is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ 15: 1723-1733
56. Feng Z. (2010). p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment. Cold Spring Harb Perspect Biol 2: a001057
57. Yu, X, Harris SL and Levine AJ. (2006). The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res 66: 4795-4801
58. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, et al. (2012). Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 14: 677-685
59. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10: 1470-1476
60. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ and Lötvall JO. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659
61. Yu, B, Zhang X and Li, X. (2014). Exosomes derived from mesenchymal stem cells. Int J Mol Sci 15: 4142-4157
62. Mokarizadeh A, Delirezh N, Morshedi A, Mosayebi G, Farshid AA and Mardani K. (2012). Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling. Immunol Lett 147: 47-54
63. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, et al. (2009). Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20: 1053-1067
64. Timmers L, Lim SK, Arslan F, Armstrong JS, Hoefer IE, Doevendans PA, et al. (2007). Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res 1: 129-137
65. Arslan F, Lai RC, Smeets MB, Akeroyd L, Choo A, Aguor EN, et al. (2013). Mesenchymal stem cell-derived exosomes increase ATP levels decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res 10: 301-312
66. Sluijter JP, Verhage V, Deddens JC, van Den Akker F and Doevendans PA. (2014). Microvesicles and exosomes for intracardiac communication. Cardiovasc Res 102: 302-311
67. Bian S, Zhang L, Duan L, Wang X, Min Y and Yu, H. (2014). Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med (Berl) 92: 387-397
68. Feng Y, Huang W, Wani M, Yu, X and Ashraf M. (2014). Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One 9: e88685
69. Yu, B, Gong M, Wang Y, Millard RW, Pasha Z, Yang Y, et al. (2013). Cardiomyocyte protection by GATA-4 gene engineered mesenchymal stem cells is partially mediated by translocation of miR-221 in microvesicles. PLoS One 8: e73304
70. Bellomo R, Kellum JA and Ronco C. (2012). Acute kidney injury. Lancet 380: 756-766
71. Hu, J, Zhang L, Wang N, Ding R, Cui S, Zhu F, et al. (2013). Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions. Kidney Int 84: 521-531
72. Humphreys BD and Bonventre JV. (2008). Mesenchymal stem cells in acute kidney injury. Annu Rev Med 59: 311-325
73. Imberti B, Morigi M and Benigni A. (2011). Potential of mesenchymal stem cells in the repair of tubular injury. Kidney Int Suppl (2011) 1: 90-93
74. Cheng K, Rai P, Plagov A, Lan X, Kumar D, Salhan D, et al. (2013). Transplantation of bone marrow-derived MSCs improves cisplatinum-induced renal injury through paracrine mechanisms. Exp Mol Pathol 94: 466-473
75. Du, T and Zhu YJ. (2014). The regulation of inflammatory mediators in acute kidney injury via exogenous mesenchymal stem cells. Mediators Inflamm 2014: 261697
76. He, J, Wang Y, Sun S, Yu, M, Wang C, Pei X, et al. (2012). Bone marrow stem cellsderived microvesicles protect against renal injury in the mouse remnant kidney model. Nephrology (Carlton) 17: 493-500
77. Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetta C, et al. (2011). Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 26: 1474-1483
78. Bruno S, Grange C, Collino F, Deregibus MC, Cantaluppi V, Biancone L, et al. (2012). Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One 7: e33115
79. Tomasoni S, Longaretti L, Rota C, Morigi M, Conti S, Gotti E, et al. (2013). Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev 22: 772-780
80. Grange C, Tapparo M, Bruno S, Chatterjee D, Quesenberry PJ, Tetta C, et al. (2014). Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging. Int J Mol Med 33: 1055-1063
81. Biancone L, Bruno S, Deregibus MC, Tetta C and Camussi G. (2012). Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant 27: 3037-3042
82. Volarevic V, Nurkovic J, Arsenijevic N and Stojkovic M. (2014). Concise review: therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem Cells 32: 2818-2823
83. Kanazawa H, Fujimoto Y, Teratani T, Iwasaki J, Kasahara N, Negishi K, et al. (2011). Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model. PLoS One 6: e19195
84. Li, T, Yan Y, Wang B, Qian H, Zhang X, Shen L, et al. (2013). Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev 22: 845-854
85. Tan CY, Lai RC, Wong W, Dan YY, Lim SK and Ho, HK. (2014). Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res Ther 5: 76
86. Zhu YG, Feng XM, Abbott J, Fang XH, Hao Q, Monsel A, et al. (2014). Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxininduced acute lung injury in mice. Stem Cells 32: 116-125
87. Yano T, Deterding RR, Simonet WS, Shannon JM and Mason RJ. (1996). Keratinocyte growth factor reduces lung damage due to acid instillation in rats. Am J Respir Cell Mol Biol 15: 433-442
88. Viget NB, Guery BP, Ader F, Nevière R, Alfandari S, Creuzy C, et al. (2000). Keratinocyte growth factor protects against Pseudomonas aeruginosa-induced lung injury. Am J Physiol Lung Cell Mol Physiol 279: L1199-L1209
89. Lee JW, Fang X, Gupta N, Serikov V and Matthay MA. (2009). Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 106: 16357-16362
90. Lee C, Mitsialis SA, Aslam M, Vitali SH, Vergadi E, Konstantinou G, et al. (2012). Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 126: 2601-2611
91. Zhang B, Wang M, Gong A, Zhang X, Wu, X, Zhu Y, et al. (2014). HucMSCexosome mediated-Wnt4 signaling is required for cutaneous wound healing. Stem Cells (Dayton Ohio). doi:10.1002/stem.1771
92. Wu, S, Ju, GQ, Du, T, Zhu YJ and Liu GH. (2013). Microvesicles derived from human umbilical cord Wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo. PLoS One 8: e61366
93. Bruno S, Collino F, Deregibus MC, Grange C, Tetta C and Camussi G. (2013). Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth. Stem Cells Dev 22: 758-771
94. Fonsato V, Collino F, Herrera MB, Cavallari C, Deregibus MC, Cisterna B, et al. (2012). Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells 30: 1985-1998
95. Munoz JL, Bliss SA, Greco SJ, Ramkissoon SH, Ligon KL and Rameshwar P. (2013). Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Mol Ther Nucleic Acids 2: e126
96. Ono M, Kosaka N, Tominaga N, Yoshioka Y, Takeshita F, Takahashi RU, et al. (2014). Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci Signal 7: ra63
97. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S and Wood MJ. (2011). Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29: 341-345
98. Lai RC, Yeo RW, Tan KH and Lim SK. (2013). Exosomes for drug delivery-a novel application for the mesenchymal stem cell. Biotechnol Adv 31: 543-551
99. Sun D, Zhuang X, Xiang X, Liu Y, Zhang S, Liu C, et al. (2010). A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther 18: 1606-1614
100. Fang Y, Wu, N, Gan X, Yan W, Morrell JC and Gould SJ. (2007). Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes. PLoS Biol 5: e158
101. Wahlgren J, De L Karlson T, Brisslert M, Vaziri Sani F, Telemo E, Sunnerhagen P, et al. (2012). Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res 40: e130
102. Pascucci L, Coccè V, Bonomi A, Ami D, Ceccarelli P, Ciusani E, et al. (2014). Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release 192: 262-270
103. Xu, X, Zhang X, Wang S, Qian H, Zhu W, Cao H, et al. (2011). Isolation and comparison of mesenchymal stem-like cells from human gastric cancer and adjacent non-cancerous tissues. J Cancer Res Clin Oncol 137: 495-504
104. Brune JC, Tormin A, Johansson MC, Rissler P, Brosjö O, Löfvenberg R, et al. (2011). Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts. Int J Cancer 129: 319-330
105. Beckermann BM, Kallifatidis G, Groth A, Frommhold D, Apel A, Mattern J, et al. (2008). VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer 99: 622-631
106. Shinagawa K, Kitadai Y, Tanaka M, Sumida T, Kodama M, Higashi Y, et al. (2010). Mesenchymal stem cells enhance growth and metastasis of colon cancer. Int J Cancer 127: 2323-2333
107. Chauhan D, Neri P, Velankar M, Podar K, Hideshima T, Fulciniti M, et al. (2007). Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM). Blood 109: 1220-1227
108. Hideshima T, Chauhan D, Kiziltepe T, Ikeda H, Okawa Y, Podar K, et al. (2009). Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple myeloma: therapeutic implications. Blood 113: 5228-5236
109. Roccaro AM, Sacco A, Maiso P, Azab AK, Tai YT, Reagan M, et al. (2013). BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest 123: 1542-1555
110. Zhu W, Huang L, Li, Y, Zhang X, Gu, J, Yan Y, et al. (2012). Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett 315: 28-37
111. Lee JK, Park SR, Jung BK, Jeon YK, Lee YS, Kim MK, et al. (2013). Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One 8: e84256
112. Furlani D, Ugurlucan M, Ong L, Bieback K, Pittermann E, Westien I, et al. (2009). Is the intravascular administration of mesenchymal stem cells safe?. Mesenchymal stem cells and intravital microscopy. Microvasc Res 77: 370-376
113. Pak HN, Qayyum M, Kim DT, Hamabe A, Miyauchi Y, Lill MC, et al. (2003). Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a Swine model of myocardial infarction. J Cardiovasc Electrophysiol 14: 841-848
114. Indira V, Corteling R, Stevanato L, Hicks C and Sinden J. (2014). The development of stem cell-derived exosomes as a cell-free regenerative medicine. J Circ Biomark 3: doi:10.5772/58597
115. Yeo RW, Lai RC, Zhang B, Tan SS, Yin Y, Teh BJ, et al. (2013). Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. Adv Drug Deliv Rev 65: 336-341
116. Pollock K, Stroemer P, Patel S, Stevanato L, Hope A, Miljan E, et al. (2006). A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp Neurol 199: 143-155
117. Chen TS, Arslan F, Yin Y, Tan SS, Lai RC, Choo AB, et al. (2011). Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J Transl Med 9: 47
118. Rani S, O'Brien K, Kelleher FC, Corcoran C, Germano S, Radomski MW, et al. (2011). Isolation of exosomes for subsequent mRNA microRNA and protein profiling. Methods Mol Biol 784: 181-195
119. Lamparski HG, Metha-Damani A, Yao JY, Patel S, Hsu DH, Ruegg C, et al. (2002). Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods 270: 211-226
120. Webber J and Clayton A. (2013). How pure are your vesicles?. J Extracell Vesicles 2: doi:10.3402/jev.v2i0.19861
121. Hupfeld J, Gorr IH, Schwald C, Beaucamp N, Wiechmann K, Kuentzer K, et al. (2014). Modulation of mesenchymal stromal cell characteristics by microcarrier culture in bioreactors. Biotechnol Bioeng 111: 2290-2302
122. Mitchell JP, Court J, Mason MD, Tabi Z and Clayton A. (2008). Increased exosome production from tumour cell cultures using the Integra CELLine Culture System. J Immunol Methods 335: 98-105
123. De Jong OG, Verhaar MC, Chen Y, Vader P, Gremmels H, Posthuma G, et al. (2012). Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles 1: doi:10.3402/jev.v1i0.18396
124. Lara AR, Galindo E, Ramírez OT and Palomares LA. (2006). Living with heterogeneities in bioreactors: understanding the effects of environmental gradients on cells. Mol Biotechnol 34: 355-381
125. King JA and Miller WM. (2007). Bioreactor development for stem cell expansion and controlled differentiation. Curr Opin Chem Biol 11: 394-398
126. Yeatts AB, Choquette DT and Fisher JP. (2013). Bioreactors to influence stem cell fate: augmentation of mesenchymal stem cell signaling pathways via dynamic culture systems. Biochim Biophys Acta 1830: 2470-2480
127. Henne WM, Buchkovich NJ and Emr SD. (2011). The ESCRT pathway. Dev Cell 21: 77-91
128. Roxrud I, Stenmark H and Malerød L. (2010). ESCRT & Co. Biol Cell 102: 293-318
129. Wollert T, Wunder C, Lippincott-Schwartz J and Hurley JH. (2009). Membrane scission by the ESCRT-III complex. Nature 458: 172-177
130. Hurley JH and Hanson PI. (2010). Membrane budding and scission by the ESCRT machinery: it's all in the neck. Nat Rev Mol Cell Biol 11: 556-566
131. Malerød L, Stuffers S, Brech A and Stenmark H. (2007). Vps22/EAP30 in ESCRT-II mediates endosomal sorting of growth factor and chemokine receptors destined for lysosomal degradation. Traffic 8: 1617-1629
132. Bowers K, Piper SC, Edeling MA, Gray SR, Owen DJ, Lehner PJ, et al. (2006). Degradation of endocytosed epidermal growth factor and virally ubiquitinated major histocompatibility complex class I is independent of mammalian ESCRTII. J Biol Chem 281: 5094-5105
133. Ghossoub R, Lembo F, Rubio A, Gaillard CB, Bouchet J, Vitale N, et al. (2014). Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2. Nat Commun 5: 3477
134. Tian T, Zhu YL, Zhou YY, Liang GF, Wang YY, Hu, FH, et al. (2014). Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery. J Biol Chem 289: 22258-22267
135. Norgan AP, Davies BA, Azmi IF, Schroeder AS, Payne JA, Lynch GM, et al. (2013). Relief of autoinhibition enhances Vta1 activation of Vps4 via the Vps4 stimulatory element. J Biol Chem 288: 26147-26156
136. Schuh AL and Audhya A. (2014). The ESCRT machinery: from the plasma membrane to endosomes and back again. Crit Rev Biochem Mol Biol 49: 242-261
137. Musante L, Tataruch De and Holthofer H. (2014). Use and isolation of urinary exosomes as biomarkers for diabetic nephropathy. Front Endocrinol (Lausanne) 5: 149
138. Amit I, Yakir L, Katz M, Zwang Y, Marmor MD, Citri A, et al. (2004). Tal a Tsg101- specific E3 ubiquitin ligase regulates receptor endocytosis and retrovirus budding. Genes Dev 18: 1737-1752
139. Lu, Q, Hope LW, Brasch M, Reinhard C and Cohen SN. (2003). TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation. Proc Natl Acad Sci USA 100: 7626-7631
140. Conibear E. (2002). An ESCRT into the endosome. Mol Cell 10: 215-216
141. Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M and Stoorvogel W. (2010). MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis. Immunol Cell Biol 88: 851-856
142. Hoshino D, Kirkbride KC, Costello K, Clark ES, Sinha S, Grega-Larson N, et al. (2013). Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Rep 5: 1159-1168
143. Hsu C, Morohashi Y, Yoshimura S, Manrique-Hoyos N, Jung S, Lauterbach MA, et al. (2010). Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J Cell Biol 189: 223-232
144. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, et al. (2010). Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 12: 19-30; supp p 1
145. Ju, R, Zhuang ZW, Zhang J, Lanahan AA, Kyriakides T, Sessa WC, et al. (2014). Angiopoietin-2 secretion by endothelial cell exosomes: regulation by the phosphatidylinositol 3-kinase (PI3K)/Akt/endothelial nitric oxide synthase (eNOS) and syndecan-4/syntenin pathways. J Biol Chem 289: 510-519
146. De Curtis I and Meldolesi J. (2012). Cell surface dynamics - how Rho GTPases orchestrate the interplay between the plasma membrane and the cortical cytoskeleton. J Cell Sci 125(Pt 19): 4435-4444
147. Fader CM, Sánchez DG, Mestre MB and Colombo MI. (2009). TI-VAMP/VAMP7 and VAMP3/cellubrevin: two v-SNARE proteins involved in specific steps of the autophagy/multivesicular body pathways. Biochim Biophys Acta 1793: 1901-1916
148. Alonso R, Mazzeo C, Rodriguez MC, Marsh M, Fraile-Ramos A, Calvo V, et al. (2011). Diacylglycerol kinase α regulates the formation and polarisation of mature multivesicular bodies involved in the secretion of Fas ligand-containing exosomes in T lymphocytes. Cell Death Differ 18: 1161-1173
149. Laulagnier K, Grand D, Dujardin A, Hamdi S, Vincent-Schneider H, Lankar D, et al. (2004). PLD2 is enriched on exosomes and its activity is correlated to the release of exosomes. FEBS Lett 572: 11-14
150. Urbanelli L, Magini A, Buratta S, Brozzi A, Sagini K, Polchi A, et al. (2013). Signaling pathways in exosomes biogenesis secretion and fate. Genes (Basel) 4: 152-170
151. Record M, Subra C, Silvente-Poirot S and Poirot M. (2011). Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol 81: 1171-1182
152. Guo Z, Turner C and Castle D. (1998). Relocation of the t-SNARE SNAP-23 from lamellipodia-like cell surface projections regulates compound exocytosis in mast cells. Cell 94: 537-548
153. Paumet F, Le Mao J, Martin S, Galli T, David B, Blank U, et al. (2000). Soluble NSF attachment protein receptors (SNAREs) in RBL-2H3 mast cells: functional role of syntaxin 4 in exocytosis and identification of a vesicle-associated membrane protein 8-containing secretory compartment. J Immunol 164: 5850-5857
154. Pelham HR. (2001). SNAREs and the specificity of membrane fusion. Trends Cell Biol 11: 99-101